4D Molecular Therapeutics Inc (FDMT)
CapEx to Revenue
1.45%
Quarterly · Period ending:
FDMT CapEx to Revenue
Latest reported1.45%period ending
Latest reported1.45%period ending
FDMT Quarterly CapEx/Revenue (0.65% → 1.45%)
Latest values, visible window
High-resolution chart · PNG
FDMT capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 1.4546% | |
| 0% | |
| 0.7416% | |
| 101.1111% | |
| 440% | |
| 4,507.1429% | |
| 94,900% | |
| 59,266.6667% | |
| 6,980% | |
| 2,535.7143% | |
| -2,889.4737% | |
| 2.0046% | |
| 336.8201% | |
| 339.5973% | |
| 87.6504% | |
| 392.8% | |
| 1,275.3086% | |
| 526.087% | |
| 5,539.1304% | |
| 192.899% | |
| 5.0549% | |
| 32.1% | |
| -51.9959% | |
| 4.7029% | |
| 3.3031% | |
| 20.396% | |
| 23.4975% | |
| 197.037% | |
| 37.6359% | |
| 37.6359% | |
| 4.2048% | |
| 4.2048% | |
| 0.651% | |
| 0.651% |